Castle Biosciences (CSTL) Change in Acquisitions & Divestments (2023 - 2025)
Castle Biosciences (CSTL) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $54.0 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 143.81% to $54.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $189.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $189.2 million for FY2025, N/A changed from the prior year.
- Change in Acquisitions & Divestments hit $54.0 million in Q4 2025 for Castle Biosciences, down from $54.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $54.9 million in Q3 2025 to a low of -$123.2 million in Q4 2024.
- Historically, Change in Acquisitions & Divestments has averaged $31.3 million across 3 years, with a median of $44.5 million in 2023.
- Biggest five-year swings in Change in Acquisitions & Divestments: crashed 354.12% in 2024 and later skyrocketed 143.81% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $48.5 million in 2023, then plummeted by 354.12% to -$123.2 million in 2024, then skyrocketed by 143.81% to $54.0 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for CSTL at $54.0 million in Q4 2025, $54.9 million in Q3 2025, and $44.0 million in Q2 2025.